rss
Arch Dis Child Fetal Neonatal Ed 2001;84:F131-F133 doi:10.1136/fn.84.2.F131
  • Short report

Amphotericin B lipid complex for neonatal invasive candidiasis

  1. F Adler-Shoheta,
  2. H Waskinb,
  3. J M Liebermana
  1. aMiller Children's Hospital, Long Beach, California and University of California, Irvine, California, USA, bThe Liposome Company, Princeton, New Jersey, USA
  1. Dr Lieberman, Pediatric Infectious Diseases, Miller Children's Hospital, 2801 Atlantic Ave, PO Box 1428, Long Beach, CA 90801–1428, USAjmlieberman{at}pol.net
  • Accepted 26 September 2000

Abstract

This study describes the safety and efficacy of amphotericin B lipid complex (ABLC) in 11 neonates with systemicCandida infections. Nine of the 11 improved clinically, and eight of nine evaluable patients had a mycological cure with ABLC. Creatinine levels improved or did not significantly change in eight of the 11 patients.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.